Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Authors
Keywords
Metformin, ki-67, Breast cancer, Clinical trial, Insulin resistance, HER2 breast cancer
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 148, Issue 1, Pages 81-90
Publisher
Springer Nature
Online
2014-09-24
DOI
10.1007/s10549-014-3141-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
- (2014) Kevin Kalinsky et al. CANCER INVESTIGATION
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment
- (2014) Michael Pollak NATURE MEDICINE
- Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials
- (2013) S. Gandini et al. ANNALS OF ONCOLOGY
- The effect of metformin on apoptosis in a breast cancer presurgical trial
- (2013) M Cazzaniga et al. BRITISH JOURNAL OF CANCER
- Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models
- (2013) P. Zhu et al. Cancer Prevention Research
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- Association Between Metformin Therapy and Mortality After Breast Cancer: A population-based study
- (2013) I. C. Lega et al. DIABETES CARE
- Potential applications for biguanides in oncology
- (2013) Michael Pollak JOURNAL OF CLINICAL INVESTIGATION
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
- (2011) Sirwan Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Lapatinib Activity in Premalignant Lesions and HER-2-Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial
- (2011) A. DeCensi et al. Cancer Prevention Research
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Cancer occurrence in Danish diabetic patients: duration and insulin effects
- (2011) B. Carstensen et al. DIABETOLOGIA
- Insulin receptor and cancer
- (2011) A. Belfiore et al. ENDOCRINE-RELATED CANCER
- Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14
- (2011) Kathleen I. Pritchard et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031
- (2011) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations
- (2011) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
- (2010) C Algire et al. ONCOGENE
- Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology
- (2009) B. Martin-Castillo et al. ANNALS OF ONCOLOGY
- Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
- (2009) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin increases plasma ghrelin in Type 2 diabetes
- (2009) Matthew P. Doogue et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Metformin in Breast Cancer: Time for Action
- (2009) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- Effect of Fenretinide and Low-Dose Tamoxifen on Insulin Sensitivity in Premenopausal Women at High Risk for Breast Cancer
- (2008) H. Johansson et al. CANCER RESEARCH
- Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
- (2008) Giuseppe Viale et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More